Related Experiment Videos
Oxyphenbutazone-induced goitre.
Postgraduate Medical Journal
|February 1, 1977
Summary
Oxyphenbutazone, used for back pain, can cause hypothyroidism by disrupting thyroid hormone production. This drug-induced thyroid dysfunction highlights a potential risk associated with long-term oxyphenbutazone use.
Area of Science:
- Endocrinology
- Pharmacology
- Thyroidology
Background:
- Oxyphenbutazone is a nonsteroidal anti-inflammatory drug (NSAID) historically used for inflammatory conditions.
- Long-term NSAID use can have various systemic effects, including potential impacts on endocrine function.
Observation:
- A patient developed goitre and hypothyroidism after 4 years of oxyphenbutazone treatment for back pain.
- The clinical presentation suggested a disruption in thyroid hormone synthesis.
Findings:
- Thyroid function tests revealed an organification defect, a key step in thyroid hormone production.
- The organification defect was attributed to the effects of oxyphenbutazone, either as a cause or an exacerbating factor.
Implications:
- This case underscores the potential for oxyphenbutazone to induce hypothyroidism through impaired thyroid hormone synthesis.
- Clinicians should consider drug-induced thyroid dysfunction in patients presenting with goitre and hypothyroidism, particularly those on long-term oxyphenbutazone therapy.
- Further research may be warranted to elucidate the precise mechanism of oxyphenbutazone's impact on thyroid organification.